Swiss CxOs Rank TCS #1 in Customer Satisfaction in Independent Survey
Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has been voted number one in customer satisfaction in Switzerland, in an independent survey of CxOs of top IT spending organizations
This is the ninth consecutive year that TCS has taken the top spot with an overall satisfaction score of 81%, compared to the industry average of 74%, reflecting TCS’ strong performance across multiple dimensions.
The independent study by Whitelane Research and Navisco AG surveyed more than 120 CxOs and senior decision makers of the top of the top IT spending organizations in the country, representing over 300 contracts with IT service providers. It evaluated 22 IT service providers over 9 key performance indicators along service delivery, relationship, commercial and transformation.
TCS took the top position in Service Quality, Account Management, Contractual Flexibility and Business Understanding. By IT domain, the company ranked first in Application Development, Maintenance and Testing.
Heinz Gehri, Country Manager, TCS Switzerland, said: "We are pleased to be ranked number one by our customers yet again. This recognition reflects our customer-centric approach and the immense value we have created for our customers by continually investing in newer capabilities. Our deep contextual knowledge of their businesses and technology landscapes, and the trust built up over the course of these long-term relationships, have made us the preferred partner in their growth and transformation journeys."
Expressing his confidence in TCS, Hansjörg Magalhaes, Global Product Manager, ERP Commercial & Supply at pharmaceutical enterprise Takeda, said: “We have been working with Tata Consultancy Services for five years now and are enjoying a true end-to-end partnership. Particularly during challenging times, TCS has proven to be a reliable partner. I am not surprised with the results of the Whitelane study, and I would like to congratulate TCS on this achievement.”
"Tata Consultancy Services has ranked first in our comprehensive customer satisfaction survey in Switzerland from the very beginning," said Jeff Loos, Head of Sourcing, Whitelane Research. "These research findings demonstrate an impressive long-term commitment and prove that TCS is a continuously reliable and innovative partner in digital transformation, even in challenging business environments."
Whitelane Research is an independent organization which conducts extensive European IT sourcing studies, as well as hosts events across the continent. In addition to publishing its annual Europe-wide report, Whitelane Research also publishes individual country-specific reports throughout the year.
India’s largest Solar and Battery Storage Project awarded to Tata Power Solar of INR 945 crore
Tata Power Solar Systems Limited (Tata Power Solar), India’s largest integrated solar company and a wholly owned subsidiary of Tata Power, has received Letter of Award (‘LoA’) from Solar Energy Corporation of India Ltd. (SECI) to build 100 MW EPC Solar project along with 120 MWh Utility Scale Battery Energy Storage System (BESS). The total contract value of the project is approximately ÌNR 945 crore. The project will be executed within 18 months. The Utility Scale EPC order book of Tata Power Solar now stands at ~4.4 GW (DC) capacity with an approximate value of INR 9,000 crore (without GST), thereby strengthening its position as India’s leading Solar EPC player
SECI project sites are located in Chhattisgarh. The order scope includes engineering, design, supply, construction, erection, testing, O&M and commissioning of the projects.
Tata Power's vision has always been to look forward to adoption of new technologies with innovation. With this win, the Company has strengthened its diversified offerings with BESS within the renewable segment.
Speaking on the achievement, Dr. Praveer Sinha, CEO & MD, Tata Power said, “We are glad to receive this prestigious order from SECI to build Solar EPC projects along with the India's largest Utility Scale BESS project. This is the second grid-scale solar plant with BESS and is recognition of Tata Power Solar’s pioneering work in project execution capabilities in the solar energy domain.”
Over the years, Tata Power Solar has been one of India’s leading solar rooftop EPC player with compelling economics, especially for the commercial and industrial segment. Tata Power Solar comes with a successful background of executing large projects, to name a few 80 MW NTPC Jetsar, 50 MW Kasargod at Kerala, 100 MW GIPCL Raghanesda, 100 MW TPREL Raghanesda, 30 MW GSECL. Another innovative Solar project of 50 MW with BESS of 50 MWh battery storage is under execution at Leh.
Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4’FY22
Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288) has received USFDA approval for its anti-allergy drug Fexofinadine Hydrochloride that is market in India under the popular brand name Allegra, among others and is the block buster drug of the innovator company Sanofi Aventis, France. Fexofinadine is most widely used, second generation antihistamine drug for the treatment of allergy symptoms and hay fever.
The company has tied-up for regular supplies of Fexofinadine to one of its top US customers, with which the company has long standing relations lasting over two decades. The company has already supplied validation quantities and the regular commercial supplies would start after approval of validation batches. Fexofinadine is a very established anti-allergy drug with a market size of around 700MT and expected to give immediate impetus to company’s export business.
Morepen is the third largest exporters of this drug to the world and will move up in the ranks after this approval. The export of Fexofenadine to the highly regulated US market is expected to see multi-fold growth resulting in better profitability margins for the company. The company is having sufficient capacity to service the present demand and is also expanding capacities to become a leading player in the product in the coming years.
Fexofinadine is among top five leading products of the company and is the fourth anti-allergy drug in the Morepen’s product basket, in addition to Loratadine, Desloratadine and Montelukast. Morepen holds a leadership position in Loratadine group since last 20 years and was first to file for marketing permissions in USA markets. Fexofinadine is marketed primarily in two dosage forms 120mg and 180mg and is available to buy over the counter in many countries including USA, Australia, New Zealand, and certain countries around Europe. It is also used in combination with other anti-allergy drugs like Montelukast for which Morepen has got the largest manufacturing capacity in the world and is already approved in US market.
Mr. Sushil Suri, Chairman and Managing Director stated, “Approval of anti-allergy drug Fexofinadine (Allegra) by USFDA is an important milestone in the company’s therapeutic journey since it consolidates Morepen’s position in the anti-allergy market with already having USFDA approval for three lead products Loratadine, Desloratadine and Montelukast. It also cements our long-standing relations with our prime customers who have worked with us for two decades and shows their confidence in company’s product quality and delivery”
Mr. Sushil Suri, Chairman and Managing Director stated, “Approval of anti-allergy drug Fexofinadine (Allegra) by USFDA is an important milestone in the company’s therapeutic journey since it consolidates Morepen’s position in the anti-allergy market with already having USFDA approval for three lead products Loratadine, Desloratadine and Montelukast. It also cements our long-standing relations with our prime customers who have worked with us for two decades and shows their confidence in company’s product quality and delivery”
Morepen has been performing extremely well for last few years and had reported strong quarterly earnings with a stellar performance in Q2’FY22 with a growth of 70 per cent in its consolidated Profits (before tax) at Rs. 46.86 crores. Profit after tax (PAT) for the quarter has jumped 38 percent at Rs. 37.36 crores. The Quarterly revenues of the company at Rs. 398.17 crores have recorded an impressive growth of 17 percent during the current quarter as compared to quarterly revenues of Rs. 340.13 crores in Q2’FY21 where in it had registered a growth of 57 percent. This is sixth quarter in a row that the company continues the fast growth trajectory with remarkable gains in the bottom line.
Mindtree has Earned the Al and Machine Learning on Microsoft Azure Advanced Specialization
Mindtree, a global technology services and digital transformation company, today announced it has earned the AI and Machine Learning on Microsoft Azure advanced specialization, a validation of a services partner’s deep knowledge, extensive experience and proven success in enabling customer adoption of AI and implementing Azure solutions for machine learning life cycle and AI-powered apps.
Only partners that meet stringent criteria around customer success and staff skilling, as well as pass a thirdparty audit of their AI and machine learning technical practices, are able to earn the AI and Machine Learning on Microsoft Azure advanced specialization.
As the speed of business accelerates, organizations of every type and size are looking for ways to streamline processes and deliver simpler, faster, and smarter resources to help them keep up. Partners with the AI and Machine Learning on Microsoft Azure advanced specialization can give organizations the tools and knowledge to develop AI solutions on their terms, build AI into their mission-critical applications, and put responsible AI into action.
“We are excited to be among Microsoft’s first service partners to have earned the AI and Machine Learning on Microsoft Azure advanced specialization,” said Radhakrishnan Rajagopalan, Global Head, Customer Success, Data and Intelligence, Mindtree. “Organizations are looking for ways to maximize business impact and revenue through augmentation and automation. As a result, AI and Machine Learning are playing an increasingly vital role in helping them unlock the full power of data for improved agility, richer experiences, smarter decision-making and reduced time-to-market. This advanced specialization validates our ability to enable organizations to optimize their digital strategies and investments, strengthening our reputation as a preferred digital transformation partner.”
Rodney Clark, Corporate Vice President, Global Partner Solutions, Channel Sales and Channel Chief at Microsoft, added, “AI and Machine Learning on Microsoft Azure advanced specialization highlights the partners who can be viewed as most capable when it comes to implementing Azure solutions for machine learning lifecycle and AI-powered apps. Mindtree clearly demonstrated that they have both the skills and the experience to enabling customer adoption of AI and Machine Learning in Microsoft Azure advanced specialization.”
Lupin Partners with lTP pie UK for Soft-mist Inhalation Technology Platform
: Lupin Inc., a wholly-owned subsidiary of global pharma major, Lupin Limited (Lupin) has entered into an agreement with TTP pie (The Technology Partnership pie) to acquire. the exclusive worldwide rights to develop, manufacture and commercialize Inhalation products using TTP's soft-mist inhalation technology platform. By leveraging this technology, Lupin expects to provide healthcare professionals with alternative solutions for delivering affordable Inhaled medicines to patients across the globe.
Soft-mist inhalation (SMI) technology allows for delivery of inhalatlon drugs from a small, portable hand-held inhaler device without the use of propellants. The individual doses are delivered using a precisely engineered nozzle system to produce a slow-moving and long-sustaining aerosol cloud. Lupin anticipates applications across respiratory care.
Lupin and TTP will jointly develop the device. Lupin will commercially manufacture the device through its network of in-house and external manufacturing locations. Lupin will also develop and manufacture formulations to be delivered through the device, obtain the necessary regulatory approvals, and commercialize the products globally.
Commenting on the development Vinita Gupta, Global CEO, Lupin said, "Inhalation is a strategic pillar of Lu pin's growth story, as we strive to bring affordable medicines to patients across the globe. The partnership with TTP for SMI technology platform Is a strategic addition to our broad Inhalation capab ilitles."
Alok Sonia, CEO- US Generics & Global RAD Head, Lupin added, "Lupin is excited to be partnering with TTP. The organizations will work together to develop products using TIP's SMI technology that complement Lu pin's portfolio of complex inhalation products."
Commenting on the development, Sam Hyde, Managing Director, TTP said, "We are excited to be partnering with Lupin to commercialize our SMI technology so that it can benefit patients suffering with chronic respiratory conditions. TIP has deep expertise In aerosol science, and we have been working with our clients for over 30 years in complex drug delivery device development - this partnership represents an exciting next step for us in this innovative area of respiratory drug · delivery."
Infosys and Proximus Extend Collaboration on IT Application Transformation and Development
Infosys a global leader in nextgeneration digital services and consulting, today announced the extension of its strategic collaboration with Proximus, Belgium’s leading digital services and communications solutions provider, to digitally transform, develop, and maintain their IT applications with leading AI and automation solutions. Through this engagement, Infosys will support Proximus’ key digital initiatives, IT transformation programs and provide structural cost reduction, in a sustainable manner.
As part of this engagement, Infosys will oversee the development, maintenance, and operations of Proximus’ IT applications in a managed service model. Infosys will also leverage its extensive partner ecosystem to accelerate the implementation of the strategic transformation programs for Proximus while ensuring optimal cost savings
Antonietta Mastroianni, Chief Digital & IT Officer, Proximus, and recent recipient of CXO of the year at the 5G Telco Awards, 2021, said, “As we continue on this journey to elevate our digital initiatives, we were looking for a partner that could understand and provide strength to our digital vision. IT services companies play an imperative role during these times of transformation. Infosys continues to be our strategic partner to drive efficiency in our IT landscape and support us in our Digital transformation journey. Having shared a bond with Infosys for over 24 years, its knowledge of the existing landscape and skilled resources will help ensure the success of our initiative. We are happy to extend this collaboration with Infosys and are looking forward to a successful journey together.”
Anand Swaminathan, Executive Vice President - Communications, Media and Technology, Infosys, said, “Proximus – Infosys’ collaboration success for more than 2 decades reflects the strong alignment in values, and the commitment to support each other during critical Industry and Business shifts. We are excited about the opportunity to support Proximus in its Digital transformation, and towards their #Inspire2022 goals.”
HERO MOTOCORP SELLS 3.5 LAKH UNITS OF MOTORCYCLES & SCOOTERS IN NOVEMBER’21
STRENGTHENS CAPABILITIES IN THE RUN UP TO THE PRODUCTION OF ELECTRIC VEHICLES IN ITS PLANT AT CHITTOOR IN ANDHRA PRADESH
Hero MotoCorp, the world’s largest manufacturer of motorcycles and scooters, registered sale of 3, 49,393 units in November 2021.
Delay in harvesting due to the late withdrawal of monsoon in many parts of the country, impacted the demand post festive season. With the economy gradually opening up coupled with several other positive indicators, such as encouraging farm activity, confident consumer index and marriage season, a swift revival in sales is expected in the fourth quarter
Additionally, commodity prices showing some signs of softening aided with the reduction of excise duty on fuel, and increased spending on Capex programs by the government is likely to bring back the momentum in the two-wheeler industry.
The company’s electric vehicles (EV) project is progressing as per plans, and the Chittoor manufacturing facility in Andhra Pradesh is gearing up to produce the green products.
The teams at Hero MotoCorp are focused on working across the entire EV eco-system such as battery technology and battery management systems, powertrain, telematics, analytics and diagnostics and charging infrastructure.
GAIL opens new round for submission of proposals from Start-Ups
In a bid to support the Start-Ups operating in identified focus areas, GAIL (India) Limited plans to invest in such companies through its Start-Up initiative 'Pankh'
GAIL has now opened a fresh Round for Solicitation of Investment Proposals from the Start-Ups operating in areas such as natural gas, petrochemicals, energy, project management, bio manure marketing, nano materials, IoT and data mining, environment, health and social, etc.
The current Solicitation Round will remain open from 1 st December, 2021 to 15th January, 2022.
Further details of focus areas are available on GAIL's website under GAIL Pankh Section. The Start-Ups that are interested in equity investment from GAIL can apply through link 'GAIL Pankh' on GAIL's website https://gailonline.com.
Biocon Enters Prestigious Dow Jones Sustainability Emerging Markets Index
Among Top 15 Companies from India on Premier Global Sustainability Benchmark
Biocon, an innovation-led global biopharmaceuticals company, today announced it has been selected to be in the Dow Jones Sustainability Index (DJSI) in the Emerging Markets (EM) category for its progressive Environmental, Social and Governance (ESG) practices, which underscore its commitment to the larger goal of sustainable development.
Biocon made a formal submission for Corporate Sustainability Assessment for its listing on the DJSI for the first time this year and made it to the DJSI EM Index with a Total Sustainability Score of 45 as against an industry average of 18, achieving a 93rd percentile position
It is among the Top 15 companies from India and one of the 12 companies from the Pharmaceuticals, Biotechnology & Life Sciences sectors to be featured in the index for 2021. A total of 360 Indian companies were invited to participate in DJSI in 2021.
Sustainability has been among Biocon’s topmost priorities since inception and both Biocon and Biocon Biologics are committed to provide insights into their ESG performance to their stakeholders.
At Biocon and Biocon Biologics we have made a conscious effort to integrate environmental, social and governance agenda into the core of our business.
As a leading global biopharmaceuticals company serving millions of patients worldwide every year, Biocon is committed to lowering the cost of life-saving therapies to bring them within the reach of people who need them the most. Our philosophy of unconditional equity extends beyond research and development of innovative therapies for patients to ensuring the well-being of people, partners, customers, shareholders, local communities and the ecosystem at large.
Our operations have been designed to enable environmental sustainability with a low carbon footprint, complete recycling of wastewater and maximum use of green power. We are committed to diversity and inclusion at the workplace and are consistently endeavoring to create a collaborative and empowering work culture, in pursuit of building businesses that make a meaningful social impact. We have established globally benchmarked standards of governance to build an environment of trust, transparency and accountability
BCPL Railway Infra bags a new order in the Khurda and Sambalpur Division of East Coast Railway
BCPL Railway Infrastructure Limited is delighted to update its esteemed stakeholders that the Company has bagged an order from the East Coast Railway, Electrical, Construction, Bhubaneswar, Head Quarters.
This order has been received for the work of “Electrification of 25 KV OHE for new line between Nuagaon to Daspalla in Khurda Division and Bichhupalli to Sonepur in Sambalpur Division of East Coast Railway including Sub-sectioning post, Traction substation and PSI work in connection with the new line.” The total project cost comprises of 2 190 million.
Commenting on the same, Mr. Aparesh Nandi, Chairman said, “We at BCPL Railway Infrastructure Limited are pleased to inform our stakeholders on our recent order intake in the Khurda and Sambalpur Division of East Coast Railway under East Coast Railway, Electrical, Construction, Bhubaneswar, Head Quarters. The value of this order is #190 million expected to be completed within 24 months. We have already started seeing inflow of orders and we are quite optimistic about the pipeline of orders in the coming months and in near future also. We expect to end the year on robust order book.”
Aurionpro announces landmark win - bags order from High Court of Madhya Pradesh.
Aurionpro is pleased to announce landmark order win from High Court of Madhya Pradesh for the complete digitisation and implementation of Video Surveillance Systems and Live Audio-Visual Streaming System.
This project is valued close to INR 190 Crores and comprises of supply, installation, commissioning and maintenance of Integrated Video Surveillance System (MPHC-IVSS) & Court Room Live AudioVisual Streaming System (MPHC-CLASS) across 48 District and Session Courts and 160 Civil Courts under the High Court of Madhya Pradesh. The tenure of the project will include implementation followed by the maintenance & support for a period of 4 years.
Mr. Yogesh Songadkar, Senior Vice President, Smart City & Mobility, while announcing this win said that “this is the first of its kind and is one of the largest such projects in India involving implementation across 1700+ court rooms in the State of Madhya Pradesh. Aurionpro is amongst leading players in System Integration and this win will further strengthen our position in this segment.”
Mr. Paresh Zaveri, Chairman & Managing Director cheering the order win stated that “We are thankful to the Hon’ble High Court of Madhya Pradesh for choosing us. This is a strategic win and will firmly place us as the preferred player for similar such projects in future. We are having a strong year in terms of growth and the string of recent wins will help us sustaining this growth trajectory for next year as well.”